MedTech Acquisition Corporation (MTAC)

Debut Date: Dec. 17, 2020

IPO Size: $250 million

Ticker: MTAC

Warrant Ticker: MTACW

Exchange: NASDAQ

Warrant Ratio: 1/3

Sponsor Family: NA

Prospectus: https://www.sec.gov/Archives/edgar/data/1826667/000110465920138083/tm2034341-5_424b4.htm

Team: 

MedTech Acquisition Corporation is led by Chairman Karim Karti, Chief Executive Officer Christopher C. Dewey, Chief Financial Officer David J. Matlin, and Chief Administrative Officer Robert H. Weiss. In addition to Messrs. Karti, Dewey, and Matlin, the Company’s Board of Directors includes Maurice R. Ferré, Martin W. Roche, and Ivan Delevic. The Company’s special advisor is Michael Stansky.

Karim Karti is a highly experienced healthcare executive. He was the Chief Operating Officer of iRhythm Technologies, Inc. (Nasdaq: IRTC), a digital healthcare company, from July 2018 until March 2020, and was instrumental in launching new products and developing alliances with leading industry participants, including Verily Life Sciences, LLC, a subsidiary of Alphabet Inc. Mr. Karti previously was an officer of General Electric Company (NYSE: GE) (“GE”), where he worked for 22 years and most recently served as President and Chief Executive Officer of the GE Healthcare Imaging division from 2016 to 2018. He also served as Chief Marketing Officer for the GE Healthcare division from 2012 to 2015, as well as the President and Chief Executive Officer of GE Healthcare Emerging Markets and GE Healthcare Korea from 2009 to 2012. Mr. Karti initially was a member of the corporate audit and M&A teams at GE from 1996 to 2000, and started his career with The Procter & Gamble Company (NYSE: PG) in Brand Management in 1993. He received his undergraduate degree from Ecole Centrale de Lyon and completed the entrepreneurship program at Ecole Superieure de Commerce de Lyon in 1992.

Christopher C. Dewey has significant experience with medical devices and has been a Managing Director of Ceros Financial Services, Inc., an investment advisory firm, since 2019. Mr. Dewey was a founding board member of MAKO Surgical Corp., a transformational robotic surgical company, where he served on the board from its initial public offering in 2008 until its $1.65 billion sale to Stryker Corp. in 2013 and held positions on the audit and compensation committees. He has been a founding investor and board member of many medical technology startups, including: Auris Surgical Robotics, Inc. from 2012 to 2014, PROCEPT BioRobotics Corp., ShockWave Medical, Inc. (Nasdaq: SWAV) from 2011 to 2014, OrthoSensor, Inc. from 2009 to 2014 and 2019 to present, DermaSensor, Inc. from 2011 to present, Horu Ophthalmics, Inc. from 2019 to present, Cephea Valve Technologies, Inc. from 2013 to 2019, GI Windows Corp., HistoSonics, Inc., Insightec, Ltd. as a board observer from 2019 to present, Magic Leap, Inc., Memic Innovative Surgery, Inc., MIVI Neuroscience, Inc. from 2018 to present, Potrero Medical, Inc., Pristine Surgical, LLC, and TriFlo Cardiovascular Inc. from 2019 to present. From 1966 to 1979, Mr. Dewey was a Founder and President of The Cannon Group, Inc. (i.e., Cannon Films), which was the one of the first independent film companies to finance, produce and distribute motion pictures worldwide. He also has had a successful career on Wall Street serving as Executive Vice President and Head of High Yield Sales at Jefferies & Co. from 1994 until 2007, and subsequently was Vice Chairman of National Securities Corp. from 2007 until 2011. Mr. Dewey was a Partner and Institutional Sales Manager in High Yield Fixed Income at Bear, Stearns & Co. from 1980 to 1990, and Managing Partner of Scully Brothers & Foss/The Marion Group, L.P. until 1994. He holds an MBA from The Wharton Graduate School of Business.

Official Site: NA

MedTech Acquisition Corporation is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus its search on businesses primarily operating in the medical technology sector in the United States.

More on MedTech Acquisition Corporation